<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7049676/table_3" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 3</label>
  <p>Indications for Treatment of Chronic HBV Infection</p>
 </caption>
 <col style="border-right:solid 1px #000000" span="1"/>
 <col style="border-right:solid 1px #000000" span="1"/>
 <col style="border-right:solid 1px #000000" span="1"/>
 <col style="border-right:solid 1px #000000" span="1"/>
 <col style="border-right:solid 1px #000000" span="1"/>
 <thead valign="top">
  <tr style="border-bottom:solid 1px #000000">
   <th align="left" colspan="5" valign="top" rowspan="1" id="0-0-e">Indications to Initiate Treatment</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td align="left" rowspan="8" colspan="1">AASLD</td>
   <td align="left" rowspan="1" colspan="1">
    <b>Treat</b>
   </td>
   <td align="left" colspan="2" rowspan="1">
    <b>Potentially Treat</b>
    <a ref-type="fn" rid="hep41480-note-0010">*</a>
   </td>
   <td align="left" rowspan="1" colspan="1">
    <b>Do Not Treat</b>
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">HBeAg‐positive</td>
   <td align="left" colspan="2" rowspan="1">HBeAg‐positive</td>
   <td align="left" rowspan="1" colspan="1">HBeAg‐positive</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">ALT elevated but &lt;2× ULN and HBV DNA &gt; 20,000 IU/mL</td>
   <td align="left" colspan="2" rowspan="1">ALT elevated &lt;2× ULN and HBV DNA ≥ 2,000 IU/mL persistent &gt;6 months</td>
   <td align="left" rowspan="1" colspan="1">ALT normal and HBV DNA &gt; 20,000 IU/mL</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Or</td>
   <td align="left" colspan="2" rowspan="1">ALT elevated ≥ 2× ULN and HBV DNA 2,000 to 20,000 IU/mL persistent &gt;6 months</td>
   <td align="left" rowspan="1" colspan="1">Or</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">HBeAg‐negative</td>
   <td align="left" colspan="2" rowspan="1">Or</td>
   <td align="left" rowspan="1" colspan="1">HBeAg‐negative</td>
  </tr>
  <tr>
   <td align="left" rowspan="3" colspan="1">ALT ≥ 2× ULN and HBV DNA &gt; 2,000 IU/mL</td>
   <td align="left" colspan="2" rowspan="1">HBeAg‐negative</td>
   <td align="left" rowspan="3" colspan="1">ALT normal and HBV DNA &lt; 2,000 IU/mL</td>
  </tr>
  <tr>
   <td align="left" colspan="2" rowspan="1">ALT normal but HBV DNA ≥ 2,000</td>
  </tr>
  <tr>
   <td align="left" colspan="2" rowspan="1">ALT elevated and HBV DNA ≥ 2,000</td>
  </tr>
  <tr>
   <td align="left" rowspan="5" colspan="1">EASL</td>
   <td align="left" rowspan="1" colspan="1">
    <b>Should be treated</b>
   </td>
   <td align="left" rowspan="1" colspan="1">
    <b>May be treated</b>
   </td>
   <td align="left" rowspan="1" colspan="1">
    <b>Can be treated</b>
   </td>
   <td align="left" rowspan="1" colspan="1">
    <b>Do not treat</b>
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">HBeAg‐positive or HBeAg‐negative</td>
   <td align="left" rowspan="4" colspan="1">HBeAg‐positive chronic HBV infection and age &gt;30 years, regardless of severity of liver histological lesions</td>
   <td align="left" rowspan="2" colspan="1">HBeAg‐positive or negative</td>
   <td align="left" rowspan="4" colspan="1">Undetectable HBV DNA, normal ALT, and mild or no liver necroinflammation and fibrosis</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Chronic HBV infection 
    <a ref-type="fn" rid="hep41480-note-0011">†</a>
   </td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">Cirrhosis with/without decompensated and any detectable HBV DNA, regardless of ALT</td>
   <td align="left" rowspan="2" colspan="1">Chronic HBV infection and family history of HCC or cirrhosis and extrahepatic manifestations</td>
  </tr>
  <tr>
   <td align="left" rowspan="1" colspan="1">HBV DNA &gt; 20,000 IU/mL and ALT &gt; 2× ULN, regardless of degree of fibrosis</td>
  </tr>
 </tbody>
 <tfoot>
  <title>Note</title>
  <p class="fn" charset="fn" id="hep41480-note-0009">
   <p>ALT upper limit of normal is defined as 35 U/L for males and 25 U/L for females.</p>
  </p>
  <p class="fn" charset="fn" id="hep41480-note-0010">
   <p class="label">*</p>
   <p>If staging indicates fibrosis ≥ F2 or activity ≥ A3, then treat regardless of HBV DNA or ALT, unless ALT normal and HBV DNA &lt; 2,000 IU/mL.</p>
  </p>
  <p class="fn" charset="fn" id="hep41480-note-0011">
   <p class="label"> † </p>
   <p>HBV &gt; 2,000 IU/mL, ALT elevated, with at least moderate liver necroinflammation or fibrosis.</p>
  </p>
  <p class="fn" charset="fn" id="hep41480-note-0012">
   <p>Abbreviations: ALT, alanine aminotransferase; CHB, chronic hepatitis B; ULN, upper limit of normal.</p>
  </p>
 </tfoot>
</table>
